HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

María Isabel Martín Selected Research

(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)

8/2012Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes.
5/2012Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.
7/2007WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat.
11/2005A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


María Isabel Martín Research Topics

Disease

5Neuralgia (Stump Neuralgia)
04/2013 - 07/2007
5Hyperalgesia
04/2013 - 11/2005
4Peripheral Nervous System Diseases (PNS Diseases)
04/2013 - 07/2007
3Painful Neuropathy
04/2013 - 05/2012
2Alzheimer Disease (Alzheimer's Disease)
03/2021 - 02/2014
2Facial Pain (Myofacial Pain)
01/2018 - 01/2010
2Pain (Aches)
05/2010 - 01/2010
2Nausea
08/2008 - 07/2007
2Pica (Geophagia)
08/2008 - 07/2007
2Vomiting
08/2008 - 07/2007
1Overweight
09/2021
1Pediatric Obesity
09/2021
1Obesity
09/2021
1Myalgia
01/2018
1Multiple Sclerosis
01/2013
1Type 2 Diabetes Mellitus (MODY)
08/2012
1Diabetic Neuropathies (Diabetic Neuropathy)
08/2012
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2012
1Gastroparesis
08/2008
1Weight Gain
07/2007
1Anorexia
07/2007
1Hypothermia
07/2007
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
06/2007

Drug/Important Bio-Agent (IBA)

6CannabinoidsIBA
03/2021 - 07/2007
6Cannabinoid Receptor AgonistsIBA
02/2014 - 11/2005
4(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
08/2012 - 11/2005
3Morphine (MS Contin)FDA LinkGeneric
01/2018 - 01/2010
3Antineoplastic Agents (Antineoplastics)IBA
04/2013 - 07/2007
3Cisplatin (Platino)FDA LinkGeneric
04/2013 - 07/2007
3Paclitaxel (Taxol)FDA LinkGeneric
05/2012 - 11/2005
2Opioid Analgesics (Opioids)IBA
01/2018 - 05/2010
2Analgesics (Analgesic Drugs)IBA
05/2010 - 01/2010
2KetamineFDA LinkGeneric
05/2010 - 01/2010
2KaolinIBA
08/2008 - 07/2007
1SolutionsIBA
09/2021
1Cholinesterase Inhibitors (Anticholinesterases)IBA
03/2021
1Loperamide (Imodium)FDA LinkGeneric
01/2018
1Opioid Receptors (Opioid Receptor)IBA
01/2018
1mu Opioid Receptors (mu Opioid Receptor)IBA
01/2018
1Natalizumab (Tysabri)FDA Link
01/2013
1Streptozocin (Streptozotocin)FDA Link
08/2012
1Minocycline (Cyclops)FDA LinkGeneric
05/2012
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2010
1Methadone (Dolophine)FDA LinkGeneric
05/2010
1Formaldehyde (Formol)FDA Link
01/2010
1Indomethacin (Indometacin)FDA LinkGeneric
01/2010
1A-factor (Streptomyces)IBA
06/2007
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
11/2005

Therapy/Procedure

2Therapeutics
09/2021 - 03/2021
2Analgesia
01/2018 - 07/2007
2Drug Therapy (Chemotherapy)
08/2008 - 07/2007